Should you buy Canopy Growth stock now?
No, the technical signal for Canopy Growth is currently SELL. Canopy Growth trades at $0.94 as of 8/6/2026. The overall technical signal is: Strong Sell. The technical analysis shows the following: MACD is negative (bearish trend) at -0.013 with rising momentum (signal: -0.018); RSI is at 48.2 (neutral zone); the stock is in a short-term uptrend (price above the 20-day average); the analyst price target of $1.23 points to 31.2% upside. The stock is in a broader downtrend (below SMA50/SMA200). Buying in a downtrend is generally not recommended. This is a technical observation based on current data, not investment advice.
What is the price target for Canopy Growth stock?
The average analyst price target for Canopy Growth is $1.23. The current price is $0.94, which gives an upside of 31.2%. Based on this, the stock is considered undervalued. The fair value range (±10% of the price target) is between $1.11 and $1.35.
Is Canopy Growth a dividend stock?
No, Canopy Growth does not currently pay a dividend to shareholders. The company reinvests its profits in growth instead of paying dividends.
What is the risk of Canopy Growth stock?
Canopy Growth is rated as a stock with extreme risk. the annual standard deviation is 100.9%, which classifies the stock as extreme risk.
Is Canopy Growth overvalued?
No, Canopy Growth is considered undervalued based on the analyst price target (31.2% upside). Canopy Growth has the following valuation ratios: a P/S ratio of 1.5, a P/B ratio of 0.8. The analyst price target suggests that the stock is undervalued by 31.2%.
Is Canopy Growth overbought?
No, Canopy Growth is not overbought. RSI is at 48.2 (neutral zone). The technical indicators show: RSI is at 48.2 (neutral zone between 30-70), which signals neither overbought nor oversold. In addition, the price is 0.7% above the 20-day average (short-term uptrend). In addition, MACD is negative, but momentum is rising (possible trend reversal).
When is the next Canopy Growth earnings report?
Canopy Growth reports its next earnings on August 7, 2026. The stock currently trades at $0.94.
Is Canopy Growth shorted?
Yes, Canopy Growth is shorted with 5.5% of the free float sold short. This is a high level of short selling, which suggests some investors are betting on falling prices. Positive surprises can lead to a moderate short squeeze. Data is updated daily based on official filings with the SEC.
Are insiders buying Canopy Growth stock?
No, insiders are not buying Canopy Growth shares – they are net sellers. Over the last 3 months, insiders have made 0 purchases and 7 sales. On a net basis, 1,816,839 $ worth of shares were sold. Across the last 20 reported transactions, the split is 0 purchases and 20 sales, with a net 1,937,125 $ sold. Active sellers include Yanofsky Theresa, Lazzarato David Angelo, BAYERN JOSEPH and others. Insider selling can have several explanations (e.g. planned 10b5-1 sales, portfolio diversification or taxes), but sustained selling by several insiders is worth watching closely.
Is Canopy Growth a good stock?
Based on our total score, Canopy Growth is rated as a poor stock with a total score of 21 out of 100. The stock scores below average on value, quality and momentum – it sits at the lower end of the market. The score is made up of Value: 48/100, Quality: 5/100, Momentum: 10/100. In addition: analysts see 31.2% upside to the price target; technical signal: Strong Sell. Whether Canopy Growth is a good investment depends on your time horizon, risk profile and portfolio. This is a data-driven observation, not investment advice.
What is the outlook for Canopy Growth stock?
The outlook for Canopy Growth based on current data: the average analyst price target is $1.23 (+31.2%); the stock is in a downtrend (below SMA50 and SMA200); the next earnings report is due on 8/7/2026, which can move the price. Keep in mind that stock prices are affected by many factors, including earnings reports, the economy and market sentiment. Past returns are no guarantee of future returns.
Why is Canopy Growth stock moving?
Canopy Growth is stable right now. The technical indicators show: the price is close to the 20-day average; short interest is 5.5% (high – many are betting on a decline); insiders have mostly been selling the stock recently. For the latest context, see our technical analysis, insider section and news overview above.
How high can Canopy Growth go?
The average analyst price target for Canopy Growth is $1.23, which corresponds to a potential gain of 31.2% from the current price of $0.94. Keep in mind that price targets are estimates, not guarantees. Actual price moves depend on earnings, market conditions and unexpected events.
How low can Canopy Growth fall?
We lack enough history to give a specific floor for Canopy Growth. Remember: past price swings are no guarantee for the future — a stock can fall further than the last 52 weeks suggest, especially on profit warnings, sector crises or a market crash. Use stop-loss orders and spread your portfolio to limit losses in single stocks.
What does Canopy Growth do?
Canopy Growth Corporation laver og sælger cannabis og hampeprodukter til både medicinsk og rekreativt brug. De tjener primært penge på at drive forretning i Canada, USA og Tyskland. Canopy Growth sælger tørrede cannabisblomster, olier og koncentrater. Blandt deres kendte mærke... The company belongs to the Sundhed sector, more specifically the Drug Manufacturers - Specialty & Generic industry, is headquartered in USA, and is traded on the USA Stocks. See the key figures, earnings history and price development above to evaluate Canopy Growth as an investment.
Did Canopy Growth raise or lower its guidance?
Over the last 60 days we have not registered a guidance raise or cut from Canopy Growth. The company can still adjust its guidance at quarterly reports or between reports — see the earnings history and the news overview above.
Is Canopy Growth making money or losing money?
No, Canopy Growth is currently not making money — the company is losing money with a negative profit margin of -92.4%, a substantial loss. That means the business loses money on every dollar of revenue. For growth stocks investing in expansion this is normal — but it raises the risk if the company does not reach break-even before its capital runs out.
Can Canopy Growth go bankrupt?
The bankruptcy risk of Canopy Growth is rated as elevated. Altman Z2 (a model for assessing financial distress) is -30.01 — that places the company in the weak zone. This is a probability based on the numbers, not a verdict — bankruptcy is not imminent. But the balance sheet is measurably weaker than average, so watch the debt, liquidity and possible capital raises. The Piotroski score (financial health 0-9, higher is better) is 3 — which is weak. Debt relative to equity is 88% (moderate). Remember: models like Altman Z2 are statistical — unexpected shocks (fraud, a sector collapse, lawsuits) can always happen. Spread your portfolio.
Does Canopy Growth have a lot of debt?
Canopy Growth has moderate debt relative to equity. The debt-to-equity ratio (D/E — interest-bearing debt to equity) is 88%. For the sundhed sector, 80-150% counts as a typical level. Note: D/E levels are highly sector-specific — a bank at 300% debt is normal, a tech stock at 300% is extremely leveraged. Always compare with similar companies in the same sector.
